BioSpace News Archive

Aquestive Therapeutics, Inc., a pharmaceutical company advancing medicines to solve patients’ problems with current standards of care and provide transformative products to improve their lives, announced the appointments of Timothy E. Morris to the Company’s Board of Directors, effective August 5, 2022, and Kenneth Truitt, M.D., as Chief Medical Officer effective September 6, 2022.

Bausch Health Companies Inc. (NYSE/TSX: BHC), and its gastroenterology business Salix Pharmaceuticals, today announced that, consistent with the company’s July 28, 2022, press release, the U.S. District Court of Delaware has issued a decision in the matter of Salix Pharmaceuticals, Ltd. et al v. Norwich Pharmaceuticals, Inc. finding certain XIFAXAN® (rifaximin) 550 mg HE patents valid and infringed and certain XIFAXAN composition and IBS-D patents invalid.

The U.S. Food and Drug Administration is providing an update on additional steps it has taken that will lead to more infant formula available in the U.S. under the agency’s recent increased flexibilities.

Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), announced today that the Taiwan Food and Drug Administration (TFDA) has accepted the submission of a New Drug Application (NDA) for Xerava™ (eravacycline) for the treatment of complicated intra-abdominal infections (cIAI).

Specialty cancer diagnostics company Precipio, Inc., welcomes Toni-Ann Mills as the Company’s Senior Director for Learning & Development.

Genmab Announces Financial Results for the First Half of 2022.

Ember Technologies, Inc. (Ember®), the global design-led temperature control brand and maker of the award-winning temperature control mug, today announced the spinout of its new healthcare vertical, Ember LifeSciences.

GLO Pharma, the parent company of breakthrough subtopical skincare brand Ourself, announces the appointment of Dayna Quanbeck to its Board of Directors.

The latest market analysis report published by Reports and Data, titled ‘Global Foot Ulcer Market – Forecast to 2030,’ thoroughly examines the Foot Ulcer industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Lipodystrophy Market – Forecast to 2030,’ thoroughly examines the Lipodystrophy industry to provide essential data & information for the targeted readers.